Selected research
Industry Research
Internal Anthelmintics for Cats Industry Research Report 2026
Market perspective
The global Internal Anthelmintics for Cats market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Internal Anthelmintics for Cats is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Internal Anthelmintics for Cats is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Internal Anthelmintics for Cats is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Internal Anthelmintics for Cats include Zoetis, Tianjin Ringpu Bio-technology, Puainta, Zhejiang Hisun Pharmaceutical, Bayer, Milbemax, Merck Animal Health, Jurox and Frontline, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Internal Anthelmintics for Cats market in terms of revenue (US$ million) and, where applicable, sales volume (kg), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/kg) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Internal Anthelmintics for Cats Market by Company
Zoetis
Tianjin Ringpu Bio-technology
Puainta
Zhejiang Hisun Pharmaceutical
Bayer
Milbemax
Merck Animal Health
Jurox
Frontline
Elanco Animal Health
Ceva Santé Animale
Bob Martin
Beaphar
Internal Anthelmintics for Cats Segment by Type
Tablets and Pills
Oral Pastes or Suspensions
Others
Internal Anthelmintics for Cats Segment by Application
Research Institutions
Veterinary Clinics
Animal Shelters
Pet Owners
Others
Internal Anthelmintics for Cats Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Internal Anthelmintics for Cats market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Internal Anthelmintics for Cats and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Internal Anthelmintics for Cats.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Internal Anthelmintics for Cats manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Internal Anthelmintics for Cats by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Internal Anthelmintics for Cats in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Tablets and Pills
- Oral Pastes or Suspensions
- Others
Applications
- Research Institutions
- Veterinary Clinics
- Animal Shelters
- Pet Owners
- Others
Companies covered
- Zoetis
- Tianjin Ringpu Bio-technology
- Puainta
- Zhejiang Hisun Pharmaceutical
- Bayer
- Milbemax
- Merck Animal Health
- Jurox
- Frontline
- Elanco Animal Health
- Ceva Santé Animale
- Bob Martin
- Beaphar
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Internal Anthelmintics for Cats Market Size (2021-2032)
- 2.2.2 Global Internal Anthelmintics for Cats Sales (2021-2032)
- 2.2.3 Global Internal Anthelmintics for Cats Market Average Price (2021-2032)
- 2.3 Internal Anthelmintics for Cats by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Tablets and Pills
- 2.3.3 Oral Pastes or Suspensions
- 2.3.4 Others
- 2.4 Internal Anthelmintics for Cats by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Research Institutions
- 2.4.3 Veterinary Clinics
- 2.4.4 Animal Shelters
- 2.4.5 Pet Owners
- 2.4.6 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Internal Anthelmintics for Cats Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Internal Anthelmintics for Cats Sales (kg) of Manufacturers (2021-2026)
- 3.3 Global Internal Anthelmintics for Cats Revenue of Manufacturers (2021-2026)
- 3.4 Global Internal Anthelmintics for Cats Average Price by Manufacturers (2021-2026)
- 3.5 Global Internal Anthelmintics for Cats Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Internal Anthelmintics for Cats, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Internal Anthelmintics for Cats, Product Type & Application
- 3.8 Global Manufacturers of Internal Anthelmintics for Cats, Established Date
- 3.9 Global Internal Anthelmintics for Cats Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Zoetis
- 4.1.1 Zoetis Company Information
- 4.1.2 Zoetis Business Overview
- 4.1.3 Zoetis Internal Anthelmintics for Cats Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Zoetis Internal Anthelmintics for Cats Product Portfolio
- 4.1.5 Zoetis Recent Developments
- 4.2 Tianjin Ringpu Bio-technology
- 4.2.1 Tianjin Ringpu Bio-technology Company Information
- 4.2.2 Tianjin Ringpu Bio-technology Business Overview
- 4.2.3 Tianjin Ringpu Bio-technology Internal Anthelmintics for Cats Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Tianjin Ringpu Bio-technology Internal Anthelmintics for Cats Product Portfolio
- 4.2.5 Tianjin Ringpu Bio-technology Recent Developments
- 4.3 Puainta
- 4.3.1 Puainta Company Information
- 4.3.2 Puainta Business Overview
- 4.3.3 Puainta Internal Anthelmintics for Cats Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Puainta Internal Anthelmintics for Cats Product Portfolio
- 4.3.5 Puainta Recent Developments
- 4.4 Zhejiang Hisun Pharmaceutical
- 4.4.1 Zhejiang Hisun Pharmaceutical Company Information
- 4.4.2 Zhejiang Hisun Pharmaceutical Business Overview
- 4.4.3 Zhejiang Hisun Pharmaceutical Internal Anthelmintics for Cats Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Zhejiang Hisun Pharmaceutical Internal Anthelmintics for Cats Product Portfolio
- 4.4.5 Zhejiang Hisun Pharmaceutical Recent Developments
- 4.5 Bayer
- 4.5.1 Bayer Company Information
- 4.5.2 Bayer Business Overview
- 4.5.3 Bayer Internal Anthelmintics for Cats Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Bayer Internal Anthelmintics for Cats Product Portfolio
- 4.5.5 Bayer Recent Developments
- 4.6 Milbemax
- 4.6.1 Milbemax Company Information
- 4.6.2 Milbemax Business Overview
- 4.6.3 Milbemax Internal Anthelmintics for Cats Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Milbemax Internal Anthelmintics for Cats Product Portfolio
- 4.6.5 Milbemax Recent Developments
- 4.7 Merck Animal Health
- 4.7.1 Merck Animal Health Company Information
- 4.7.2 Merck Animal Health Business Overview
- 4.7.3 Merck Animal Health Internal Anthelmintics for Cats Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Merck Animal Health Internal Anthelmintics for Cats Product Portfolio
- 4.7.5 Merck Animal Health Recent Developments
- 4.8 Jurox
- 4.8.1 Jurox Company Information
- 4.8.2 Jurox Business Overview
- 4.8.3 Jurox Internal Anthelmintics for Cats Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Jurox Internal Anthelmintics for Cats Product Portfolio
- 4.8.5 Jurox Recent Developments
- 4.9 Frontline
- 4.9.1 Frontline Company Information
- 4.9.2 Frontline Business Overview
- 4.9.3 Frontline Internal Anthelmintics for Cats Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Frontline Internal Anthelmintics for Cats Product Portfolio
- 4.9.5 Frontline Recent Developments
- 4.10 Elanco Animal Health
- 4.10.1 Elanco Animal Health Company Information
- 4.10.2 Elanco Animal Health Business Overview
- 4.10.3 Elanco Animal Health Internal Anthelmintics for Cats Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Elanco Animal Health Internal Anthelmintics for Cats Product Portfolio
- 4.10.5 Elanco Animal Health Recent Developments
- 4.11 Ceva Santé Animale
- 4.11.1 Ceva Santé Animale Company Information
- 4.11.2 Ceva Santé Animale Business Overview
- 4.11.3 Ceva Santé Animale Internal Anthelmintics for Cats Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Ceva Santé Animale Internal Anthelmintics for Cats Product Portfolio
- 4.11.5 Ceva Santé Animale Recent Developments
- 4.12 Bob Martin
- 4.12.1 Bob Martin Company Information
- 4.12.2 Bob Martin Business Overview
- 4.12.3 Bob Martin Internal Anthelmintics for Cats Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Bob Martin Internal Anthelmintics for Cats Product Portfolio
- 4.12.5 Bob Martin Recent Developments
- 4.13 Beaphar
- 4.13.1 Beaphar Company Information
- 4.13.2 Beaphar Business Overview
- 4.13.3 Beaphar Internal Anthelmintics for Cats Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Beaphar Internal Anthelmintics for Cats Product Portfolio
- 4.13.5 Beaphar Recent Developments
5 Global Internal Anthelmintics for Cats Market Scenario by Region
- 5.1 Global Internal Anthelmintics for Cats Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Internal Anthelmintics for Cats Sales by Region: 2021-2032
- 5.2.1 Global Internal Anthelmintics for Cats Sales by Region: 2021-2026
- 5.2.2 Global Internal Anthelmintics for Cats Sales by Region: 2027-2032
- 5.3 Global Internal Anthelmintics for Cats Revenue by Region: 2021-2032
- 5.3.1 Global Internal Anthelmintics for Cats Revenue by Region: 2021-2026
- 5.3.2 Global Internal Anthelmintics for Cats Revenue by Region: 2027-2032
- 5.4 North America Internal Anthelmintics for Cats Market Facts & Figures by Country
- 5.4.1 North America Internal Anthelmintics for Cats Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Internal Anthelmintics for Cats Sales by Country (2021-2032)
- 5.4.3 North America Internal Anthelmintics for Cats Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Internal Anthelmintics for Cats Market Facts & Figures by Country
- 5.5.1 Europe Internal Anthelmintics for Cats Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Internal Anthelmintics for Cats Sales by Country (2021-2032)
- 5.5.3 Europe Internal Anthelmintics for Cats Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Internal Anthelmintics for Cats Market Facts & Figures by Country
- 5.6.1 Asia Pacific Internal Anthelmintics for Cats Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Internal Anthelmintics for Cats Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Internal Anthelmintics for Cats Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Internal Anthelmintics for Cats Market Facts & Figures by Country
- 5.7.1 South America Internal Anthelmintics for Cats Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Internal Anthelmintics for Cats Sales by Country (2021-2032)
- 5.7.3 South America Internal Anthelmintics for Cats Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Internal Anthelmintics for Cats Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Internal Anthelmintics for Cats Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Internal Anthelmintics for Cats Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Internal Anthelmintics for Cats Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Internal Anthelmintics for Cats Sales by Type (2021-2032)
- 6.1.1 Global Internal Anthelmintics for Cats Sales by Type (2021-2032) & (kg)
- 6.1.2 Global Internal Anthelmintics for Cats Sales Market Share by Type (2021-2032)
- 6.2 Global Internal Anthelmintics for Cats Revenue by Type (2021-2032)
- 6.2.1 Global Internal Anthelmintics for Cats Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Internal Anthelmintics for Cats Revenue Market Share by Type (2021-2032)
- 6.3 Global Internal Anthelmintics for Cats Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Internal Anthelmintics for Cats Sales by Application (2021-2032)
- 7.1.1 Global Internal Anthelmintics for Cats Sales by Application (2021-2032) & (kg)
- 7.1.2 Global Internal Anthelmintics for Cats Sales Market Share by Application (2021-2032)
- 7.2 Global Internal Anthelmintics for Cats Revenue by Application (2021-2032)
- 7.2.1 Global Internal Anthelmintics for Cats Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Internal Anthelmintics for Cats Revenue Market Share by Application (2021-2032)
- 7.3 Global Internal Anthelmintics for Cats Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Internal Anthelmintics for Cats Value Chain Analysis
- 8.1.1 Internal Anthelmintics for Cats Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Internal Anthelmintics for Cats Production Mode & Process
- 8.2 Internal Anthelmintics for Cats Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Internal Anthelmintics for Cats Distributors
- 8.2.3 Internal Anthelmintics for Cats Customers
9 Global Internal Anthelmintics for Cats Analyzing Market Dynamics
- 9.1 Internal Anthelmintics for Cats Industry Trends
- 9.2 Internal Anthelmintics for Cats Industry Drivers
- 9.3 Internal Anthelmintics for Cats Industry Opportunities and Challenges
- 9.4 Internal Anthelmintics for Cats Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst